FDA accepts safety data for canine longevity drugJanuary 13, 2026Loyal advances toward market approval with acceptance of Target Animal Safety section for its senior dog lifespan extension drug, LOY-002.
SPONSORED CONTENTScience In Every StepFeel confident knowing every step a Librela (bedinvetmab injection) treated dog takes is backed by science + Learn More
NAVC announces the 2025 VETTY Awards winnersJanuary 13, 2026Entrants to the annual marketing excellence competition included agencies and companies in veterinary clinics, pet pharmaceuticals, foods, diagnostic equipment, professional associations, and advocacy groups.
Generic robenacoxib tablet for post-op pain and inflammation in cats OK-ed by the FDAJanuary 11, 2026The product is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration in cats at least four months old and weighing at least 5.5 lbs.
Brain Teaser: Can you solve this puzzle?January 7, 2026Presentation: A five-month-old intact female Pomeranian with right forelimb lameness after jumping off a step.
Veterinarians urged to share heartworm incidence dataJanuary 6, 2026The American Heartworm Society (AHS) calls upon veterinarians to submit clinic data to support updated national mapping of heartworm disease trends in the United States.
USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an anti–IL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
AVMA lists down New Year's resolutions vet clinics can share with clientsDecember 30, 2025As 2026 begins, the American Veterinary Medical Association (AVMA) encourages pet owners to prioritize their animals’ health and happiness with simple resolutions. Check out key points you can share with clients as we ring in the New Year.
Holidays bring rise in pet emergencies, insurance data showsDecember 23, 2025An analysis of one million insured pets show the sharp increase in pet health emergencies during the holidays, with claims rising 182 percent in the final two weeks of the year and average treatment costs reaching about $814. Learn more about what to warn pet owners about this season.
FDA conditionally approves drug for New World screwworm infestation in dogsDecember 23, 2025The U.S. Food and Drug Administration (FDA) conditionally approves Credelio Quattro-CA1 for treating New World screwworm (NWS) infestations in young dogs and puppies.
Canine parvo preventative gets full USDA approvalDecember 16, 2025The product, now approved as a therapeutic for canine parvovirus, marks the first USDA-approved treatment for the disease beyond supportive care and will be marketed under the name Trutect.
